Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBDW price surge!! https://youtube.com/shorts/4-Nkoft-lCk
Weekly Stock Analysis and Innovation Spotlight: 1606 Corp $CBDW https://allcapresearch.com/f/weekly-stock-analysis-and-innovation-spotlight-1606-corp-cbdw
ELEV..................EOSE.......................https://stockcharts.com/h-sc/ui?s=EOSE&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=ELEV&p=D&yr=0&mn=2&dy=12&id=p84071410134
Dalrada $DFCO just joined the prestigious Minority Business RoundTable! This move opens doors to significant government and private contracts, boosting growth potential. This strategic partnership will drive future success! #investing #Growth https://dalrada.com/dalrada-joins-minority-business-roundtable/
Dalrada $DFCO just joined the prestigious Minority Business RoundTable! This move opens doors to significant government and private contracts, boosting growth potential. This strategic partnership will drive future success! #investing #Growth https://dalrada.com/dalrada-joins-minority-business-roundtable/
The Corporate Race For Implementing AI Is Hot. Here’s How To Get Ahead -- $CBDW https://www.linkedin.com/feed/update/urn:li:activity:7213496571961753601/
$EWRC Press release next week will encompass current and future projects. It will also include our 1st person POV game schedule with a detailed roadmap with one of the gaming world’s premiere platforms.
$EWRC’s press release next week will encompass current and future projects. It will also include our 1st person POV game schedule with a detailed roadmap with one of the gaming world’s premiere platforms.
— eWorld Companies, Inc (@eworld_company) June 28, 2024
HUGE ALERTS: >>> $BSEM https://hugealerts.com/bsem/
$BSEM BioStem Technologies Inc. (OTC: BSEM)
$MMMW announces debt elimination to prepare for a new marketable product.
EFOI.................MULN..................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=EFOI&p=D&yr=0&mn=2&dy=12&id=p84071410134
KYNC https://finance.yahoo.com/news/kyn-capital-groups-koinfold-integrates-123000230.html WILL RUN HUGE...
New Growth Report BioStem Technologies, Inc. (OTC: $BSEM)
BSEM Key Highlights
Completed an extensive two-year audit in preparation for moving BSEM to a national exchange. (NASDAQ or NYSE)
Recently released their Q1 earnings, which shocked the market with revenues totaling $41 million in the first quarter of 2024.
First positive net income of over $4.4 million in the quarter.
Analyst Target $23.75 representing a 153% upside from the current price of $9.38
Regenerative medicine leverages the body's natural systems to rebuild tissues and organs. It is expected to revolutionize healthcare, with the global stem cell market projected to reach $18.4 billion by 2028.
Take a minute to look at the full analysis and disclosures >>> https://tradersnewssource.com/wp-content/uploads/2024/06/TNS-BSEM-growth-report-6-27-24.pdf
VERU...................................https://stockcharts.com/h-sc/ui?s=VERU&p=D&yr=0&mn=3&dy=0&id=p11960084343
LWLG making internet go faster with less energy
https://www.lightwavelogic.com/
https://ih.advfn.com/stock-market/NASDAQ/lightwave-logic-LWLG/stock-news/93897290/lightwave-logic-and-advanced-micro-foundry-amf-par
NNVC...................MULN................................https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=NNVC&p=W&b=5&g=0&id=p84354014936
$PWDY Copy of a tweet I just saw ============ #PWDY Update: Stay tuned for more exciting company updates next week. The company would like to thank all our loyal shareholders for believing in us and helping spread the word about Powerdyne. #updates #investors #pwdy
$CBDW 1606 Corp AI market heating up 0530 short
NNVC.......................MULN...........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=NNVC&p=D&yr=0&mn=3&dy=0&id=p11960084343
$CBDW Enhancing Investor Relations with AI Technology
https://www.linkedin.com/feed/update/urn:li:activity:7208497960932839424/
$IFUS Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
May 13, 2024 9:15 AM EDT | Source: Impact Fusion International Inc.
Napoleonville, Louisiana--(Newsfile Corp. - May 13, 2024) - Impact Fusion International Inc. (OTC Pink: $IFUS ) The Company is pleased to announce that a research project with the Southern University Agricultural and Research Center (SUARC) has begun. Research representatives from SUARC will collect samples of SGP+™ and sugarcane bagasse from IFUS' Napoleonville, LA Operations on Thursday May 16, 2024. This effort occurred after the SUARC team visited the Napoleonville LA site several weeks ago. They then met with ranchers successfully applying SGP+™ to their herds to hear firsthand of success stories regarding the efficacy of SGP+™ to ranching operations. During the visit on May 10, 2024, the Company was introduced to the Graduate student who was assigned to the project.
A Memorandum of Understanding (MOU) has been drafted between IFUS and SUARC. The first wave lab analysis for the Project "Improving Sugar Cane Bagasse Through Various Treatments to Create High-Quality Livestock Feed from Southern University Baton Rouge (SUBR)" will take about 3 months. At that point, a new MOU will be executed based on findings from this initial study.
During the visit, the SUBR Team commented on the validation that there was an immediate shift in the exothermic (heat releasing) transition of sugarcane bagasse to an endothermic (heat absorbing or cooling) of SGP+™. The transition was so immediate and so pronounced, that the team has engaged in the next level of testing of SGP+™ as compared to basic sugarcane bagasse.
As described by the SUARC Lead Scientist, if, in fact, IFUS has discovered how to breakdown the lignin of sugarcane bagasse in SGP+™, this is "The Holy Grail" of energy and nutrition and possibly a hay replacement. This could further substantiate observations and qualitative analysis being reported by ranchers and dairymen, who consistently report improved herd performance, lower costs, higher revenue generation for sale of cattle, Carbon-footprint and Green House Gas reduction, and more.
This initial round of studies will continue to target the depolymerization of lignin. Centuries of research have attempted to find a viable application of sugarcane bagasse and other materials high in lignin content. Lignin is considered to be the second most abundant biomass material on the planet. The implications of further understanding lignin degradation for application of beef and dairy herds are enormous (with implications for commercial application well beyond this significant, yet singular application)…all while reducing the Global Carbon Footprint. Considering the 1.5-Billion cows, bulls, calves, and steers, this could well become one of the most powerful Green-to-Gold Solutions discovered on planet Earth, thus far.
The research is expected to last 3 months and has already commenced. SUARC will publish their findings at the end of the initial study.
"We are excited about the opportunity afforded us by SUARC to conduct the research to potentially validate our grass roots findings as reported to us by our ranchers and farmers," stated Marc Walther, President and CEO.
Back to Work
Our 1-800-775-4130 is always open for questions and you may also reach us at: impactfusionintl@gmail.com.
About Impact Fusion International Inc.
Impact Fusion International, Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well-being of humans and animals. The information contained in this release includes some statements that are not purely historical and that are "forward-looking statements." Such forward-looking statements include, but are not limited to, statements regarding our and their management's expectations, hopes, beliefs, intentions or strategies regarding the future, including our financial condition, results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipates," "believes," "continue," "could," "estimates," "expects," "intends," "may," "might," "plans," "possible," "potential," "predicts," "projects," "seeks," "should," "would" and similar expressions, or the negatives of such terms, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this release are based on current expectations and beliefs concerning future developments and the potential effects on the parties and the corporate and administrative transactions. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.
Contact: Impact Fusion International Inc. 204 Highway 1011 Napoleonville LA 70390 1-800-775-4130
Email: impactfusionintl@gmail.com
Website: https://www.impactfusionbrands.com/brand
Twitter: @impactfusionI
#bagasse #methanegases #drought #cattle #dairy #research #SUARC #floods #wildfires #hay
info
SOURCE: Impact Fusion International Inc.
Launch pad : #1 $PSRU
#2 $SAPX
#3 $AHRO
DPUI.....................................https://stockcharts.com/h-sc/ui?s=DPUI&p=D&yr=0&mn=2&dy=12&id=p84071410134
$AIMD -Ainos | NEWS! Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA https://www.accesswire.com/877292/ainos-unveils-critical-progress-in-ainos-flora-clinical-trials-and-next-gen-plans-powered-by-nvidia-cuda
$AIMD KEEP ON THE RADAR - HEARING HUGE NEWS COMING VERY SOON....
$TMGI HAS BIG NEWS COMING SOON! $ULTA
$TMGI year end 5/31, 10–K now underway. With the $ULTA agreement complete, we’re expanding the @SimplyWhim reach with a new marketing campaign and updated Whim products. More to come. Stay Tuned! https://t.co/rCPwU70MAM pic.twitter.com/U4n2hyos5a
— TMGI (@TheMarquieGroup) June 12, 2024
PDYN: PallaDyne AI Corp : Unknown low float AI software play rght at breakout. AI crowd finding. They are gonna rip it.
GOEV....................MULN..............................https://stockcharts.com/h-sc/ui?s=GOEV&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
$AIMD The chart is poised for a perfect buy opportunity from here https://schrts.co/qCsPCgtF
$RDAR EPIC NEWS COMING SOON ABOUT A BLOCKBUSTER PARTNERSHIP 👇👇
$RDAR EPIC NEWS COMING SOON ABOUT A BLOCKBUSTER PARTNERSHIP 🏈🏈
— RAADR.com (@raadr_) June 5, 2024
Ainos, Inc. (NASDAQ: $AIMD) devotes to building telehealth-enabled healthcare with AI-powered point-of-care testing (POCT), VELDONA therapeutics, and synthetic RNA. Our name, Ainos, combines "AI" and "Nose." Join our journey.
$NRXP News: NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
The June 2024 meeting of the American Society for Clinical Psychopharmacology (ASCP) focused heavily on increasing use of intravenous ketamine and intranasal S-ketamine as the emerging standard of care for treating severe depression and suicidality
Presenters from 3 open label studies at the ASCP suggested that intravenous ketamine is at least equivalent and may have advantages over intranasal S-ketamine
NRx Pharmaceuticals has now reached the 9-month stability point with its ketamine formulation (NRX-100) and has initiated 3 manufacturing lots for future drug release. Nonclinical safety for short term use of NRX-100 has recently been published and submitted to FDA
FDA leadership, in public comments at ASCP, focused on the need for nonclinical safety data for intravenous ketamine as a condition of ketamine approval
The short-term need for intravenous ketamine as an already-approved, schedule 3 drug, is heightened by recent regulatory decisions that may delay the path of potent, schedule 1 psychedelic drugs that may require more complicated clinical trial designs.
RADNOR, Pa., June 10, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that the Company posted a new Shareholder Update Letter on its website NRx Shareholder Update and further invites interested parties to subscribe to their email alert service to stay up to date on company's progress here: NRx Email Alerts . (Note: not all updates will be included in a Press Release in the future).
Today's update highlights potential implications of the Company's recent activities at the annual meeting of the American Society of Clinical Psychopharmacology. The key points include:
Intravenous and intranasal ketamine were highlighted as emerging standards of care for severe depression and suicidality
Planned NDA filing for NRX-100, our preservative free IV ketamine, for Suicidal Depression in 2024, is based on well controlled trials against both placebo and active comparator. Fast Track Designation was previously granted
An independent FDA advisory panel recently voted against MDMA, a potent, class I psychedelic, refocusing attention on already-approved Schedule 3 drugs such as ketamine for treatment of suicidal depression. The FDA panel and emerging guidance highlights the complexity of clinical trials of DEA Schedule 1 hallucinogens that do not have already-approved human uses
NRx anticipates that an important issue for longer term use of ketamine in depression will be the current multidose vial presentation that contains potentially toxic preservatives previously acceptable for one time use but less suitable for repeated use. NRX-100 is planned as a single-dose, preservative-free medication.
Please subscribe to the Company's email for future updates. NRX Email Alerts Not all of these will be the subject of a Press Release in the future.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine), in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals, focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression, together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=CL35448&sd=2024-06-10 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-publishes-shareholder-update-letter-302168228.html
SOURCE NRx Pharmaceuticals, Inc.
NNVC.................MULN..................................https://stockcharts.com/h-sc/ui?s=NNVC&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
$CBDW Exciting times ahead for customer service.
At CBDWAI, we believe hashtag#AI is revolutionizing the customer experience. Here are six ways AI will shape the future: https://www.linkedin.com/feed/update/urn:li:activity:7203464137056616448/
$AAPJ Now_Pink_Current and News IS on the Way!
When the company turns Pink Current on OTC Markets a news release will be provided. $AAPJ
— AAP, INC. Stock Symbol, AAPJ (@TheRealAAPJ) May 29, 2024
#BREAKINGNEWS: Rodedawg (OTC: $RWGI) Expands into Dispensary Acquisitions and Signs Letter of Intent for Dispensary License https://www.globenewswire.com/news-release/2024/06/06/2894594/0/en/Rodedawg-OTC-RWGI-Expands-into-Dispensary-Acquisitions-and-Signs-Letter-of-Intent-for-Dispensary-License.html
$CBDW 1606 Corp. to Host Exclusive Live Investor Webinar and Q&A Session on June 11th https://finance.yahoo.com/news/1606-corp-host-exclusive-live-120000020.html
10x Penny Stock Opportunity $RWGI, The DEA is moving to reclassify Marijuana
At $CBDW AI, we believe hashtag#AI is revolutionizing the customer experience. Here are six ways AI will shape the future: https://www.linkedin.com/posts/greg-lambrecht_ai-ai-customerservice-activity-7203464137056616448-RWnh/?utm_source=share&utm_medium=member_desktop
$AIMD Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market https://finance.yahoo.com/news/ainos-initiate-clinical-study-potential-120000724.html
#BreakingNews: Rodedawg (OTC: $RWGI) Announces Successful Launch of Nutrient CBD Product Line https://finance.yahoo.com/news/rodedawg-otc-rwgi-announces-successful-120000632.html
Rodedawg (OTC: $RWGI) ON HIGH ALERT -- HEARING HUGE NEWS/UPDATE COMING ANY DAY NOW!!!
https://x.com/RWGImerger
$AIMD - @AinosInc Ainos | AI + Nose showcased its innovation at #COMPUTEX #technology conference in Taipei this week. NVIDIA #CEO highlighted the future of #AI, emphasizing the significance of physical #AI that understands the laws of physics and can work alongside us.
According to Huang, #robotics and $AI will play a crucial role in future developments. The robots are going to need a nose.
#GIVEMENOSE
Explore more insights from the event here: [Read more](https://blogs.nvidia.com/blog/temp-computex-2024-jensen-huang/)
$DBMM>OTC INVESTMENT for 10,000% to 100,000%+ GAINS.
Growth towards NASDAQ has started as per below recent PRs, updates and tweets.
Many 10,000%+ runs coming. Just like last 2 10,000% and a 40,000% run.
Just getting started for next one.
With below, $DBMM setting up for NASDAQ = $$,$$$,$$$$
Digital Clarity Announces Strategic Alliance with Leading Transformation Consultancy 1ovmany.
Press Release - April 11, 2024.
https://www.accesswire.com/852296/digital-clarity-announces-strategic-alliance-with-leading-transformation-consultancy-1ovmany
"Company is pleased to announce the acquisition of a major software client headquartered in Austin Texas."
Shareholders Update - February 02, 2024.
https://www.dbmmgroup.com/shareholder-update-february-02-2024/
$DBMM MARCH 12, 2024 SHAREHOLDER UPDATE
https://www.dbmmgroup.com/shareholder-update-march-12-2024/
$DBMM in today's News "additional partnerships and/or strategic alliances to augment its offering with various organizational/ transformational initiatives, including AI and other applications to be integrated with existing marketing solutions"
We will be specifically describing a series of meetings we have recently held which are being finalized and will result in other avenues to maximize revenue streams for all parties. Everyone wins.
Linda Perry and Reggie Jame
✅Why chose DBMM?
— DBMM Group Inc. (@dbmm_group) August 3, 2023
Positioned to disrupt multitrillion-dollar global market
Ground-floor investment opportunity
Comparisons to GameStop and AMC
▶️ https://t.co/3gFUr4fIVi#DBMM #OTC pic.twitter.com/fqIdWQMtjy
DBMM is positioned in the multitrillion-dollar global marketing consultancy market
— DBMM Group Inc. (@dbmm_group) October 24, 2023
DBMM’s Digital Clarity has a:
•Extensive black book
•Robust client base
•Current territories: Europe and U.S
•Future territories: U.A.E. and Asia pic.twitter.com/5gqpFWzbUV
$IVDN News on sales surge for superior, energy saving house wrap: Innovative Designs Sales Update
PITTSBURGH, PA- (NewMediaWire) - May 30, 2024 - Innovative Designs, Inc. (OTCQB: IVDN) continues its upward sales trend into the end of May 2024. Year-to-date sales have already surpassed FYE2023 by over 33% with 5 months remaining in FYE2024. The growth is attributed to a substantial increase in the number of new retailers that are now carrying the company's Insultex House Wrap®. As new energy codes are implemented across the United States, homebuilders/contractors are using Insultex House Wrap® as a convenient R-Value continuous insulation to a wall system.
Our notable growth in sales can be attributed to Built Link Solutions (Formerly Compound Construction) based in Grand Rapids, MI. Built Link Solutions is working to become the primary source for industry professionals, innovators, and stakeholders to discover, evaluate, and adopt the latest advancements in building materials, tools and technologies. Having curated a comprehensive national distribution network, they bring pioneering solutions like Insultex House Wrap® to market, propelling the evolution of the construction industry towards a future where innovation thrives, and buildings meet the needs of tomorrow. Since coming onboard, Built Link Solutions has:
Established a comprehensive national distribution network to service customers where they are when they need it.
Grown national awareness of product benefits and specifications through their dedicated sales agents and attendance at building industry trade shows across the country.
Conducted in-person sales training and online seminars to educate sales associates on Insultex House Wrap®.
Streamlined the sales process to deliver consistent and superior level service to customers of all sizes and needs.
Implemented volume pricing models and incentive discounts to meet the needs for scale and demand.
As building codes and exterior R-Value requirements are quickly evolving across the country, Built Link Solutions has proven highly proactive in contacting prospective accounts, notifying them of the cost-effective solution that our Insultex House Wrap® provides.
Randy Kimbler, Director of Business Development for Built Link Solutions, commented, "Insultex House Wrap® is gaining traction in the market as it provides a timely and effective solution. Its cost-effectiveness, innovation, and ability to address today's building challenges are driving positive feedback nationwide."
About Innovative Designs, Inc.
Innovative Designs, Inc. manufactures the Insultex® House Wrap and Arctic Armor® Line, under the "i.d.i.gear" label featuring INSULTEX®. Patented INSULTEX® is the thinnest, lightest, and warmest insulator in the market today. For more information, please visit:
http://www.idigear.comorhttp://www.insultexhousewrap.com.
Disclaimer
Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available athttp://www.sec.gov.
CONTACT:
Innovative Designs, Inc.
Joseph Riccelli, CEO
412-799-0350
joer@idigear.com
http://www.insultexhousewrap.com
Built Link Solutions
Randy Kimbler, Dir. Business Development
616-443-3200
RandyK@Builtlinksolutions.com
News Source: Innovative Designs Inc.
FFIE.........................MULN.................................https://www.mullenusa.com/mullen-go
$CBDW 1606 Corp AI market heating up 0530 short
DPUI...............................https://www.stockscores.com/charts/charts/?ticker=DPUI
$CBDW KEEP ON THE RADAR -- HEARING HUGE UPDATE COMING SOON...
Followers
|
1526
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
84375
|
Created
|
03/06/15
|
Type
|
Free
|
Moderator PennyMaster | |||
Assistants Golden Cross hstang04 Garyst BLULLISH |
*DISCLAIMER*
•The Board Moderator and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• Always do your own due diligence with any stock you may consider buying and never invest more than you are willing to lose.
• Stocks mentioned here may or may not be held by members posting on this board.
• There are no guarantees when buying or selling any security.
Posts Today
|
0
|
Posts (Total)
|
84375
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |